Brokerages expect that Prestige Consumer Healthcare Inc (NYSE:PBH) will report sales of $252.05 million for the current quarter, according to Zacks. Four analysts have provided estimates for Prestige Consumer Healthcare’s earnings, with the lowest sales estimate coming in at $250.70 million and the highest estimate coming in at $254.80 million. Prestige Consumer Healthcare posted sales of $270.62 million in the same quarter last year, which suggests a negative year-over-year growth rate of 6.9%. The business is expected to report its next earnings report on Thursday, February 7th.
According to Zacks, analysts expect that Prestige Consumer Healthcare will report full-year sales of $988.98 million for the current year, with estimates ranging from $985.00 million to $991.60 million. For the next financial year, analysts forecast that the business will post sales of $983.53 million, with estimates ranging from $980.20 million to $987.50 million. Zacks Investment Research’s sales calculations are an average based on a survey of analysts that that provide coverage for Prestige Consumer Healthcare.
Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings results on Thursday, November 1st. The company reported $0.65 EPS for the quarter, topping analysts’ consensus estimates of $0.63 by $0.02. Prestige Consumer Healthcare had a return on equity of 11.82% and a net margin of 33.38%. The company had revenue of $239.36 million during the quarter, compared to analyst estimates of $236.28 million. During the same quarter last year, the firm posted $0.61 earnings per share. The firm’s revenue was down 7.2% on a year-over-year basis.
In other Prestige Consumer Healthcare news, EVP Timothy Connors sold 34,000 shares of the firm’s stock in a transaction on Monday, November 19th. The stock was sold at an average price of $38.25, for a total transaction of $1,300,500.00. Following the completion of the transaction, the executive vice president now owns 25,775 shares of the company’s stock, valued at $985,893.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.14% of the company’s stock.
A number of institutional investors have recently made changes to their positions in PBH. Bank of Montreal Can increased its holdings in shares of Prestige Consumer Healthcare by 135.9% during the second quarter. Bank of Montreal Can now owns 3,067 shares of the company’s stock valued at $118,000 after acquiring an additional 1,767 shares in the last quarter. Zions Bancorporation bought a new position in shares of Prestige Consumer Healthcare during the second quarter valued at $137,000. Tower Research Capital LLC TRC increased its holdings in shares of Prestige Consumer Healthcare by 338.0% during the third quarter. Tower Research Capital LLC TRC now owns 3,754 shares of the company’s stock valued at $142,000 after acquiring an additional 2,897 shares in the last quarter. Rehmann Capital Advisory Group increased its holdings in shares of Prestige Consumer Healthcare by 4,166.4% during the third quarter. Rehmann Capital Advisory Group now owns 5,077 shares of the company’s stock valued at $134,000 after acquiring an additional 4,958 shares in the last quarter. Finally, BlueMountain Capital Management LLC bought a new position in shares of Prestige Consumer Healthcare during the second quarter valued at $208,000.
PBH stock traded down $0.20 on Wednesday, reaching $31.30. The company’s stock had a trading volume of 26,016 shares, compared to its average volume of 378,790. Prestige Consumer Healthcare has a 12-month low of $27.84 and a 12-month high of $46.44. The firm has a market capitalization of $1.61 billion, a price-to-earnings ratio of 12.31, a PEG ratio of 1.54 and a beta of 1.01. The company has a quick ratio of 1.38, a current ratio of 2.15 and a debt-to-equity ratio of 1.59.
About Prestige Consumer Healthcare
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.
Featured Story: What is a stock split?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.